Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

Benzinga Newsdesk www.benzinga.com Neutral 56.7%

Neg 0% Neu 56.7% Pos 0%

Barclays analyst Christopher Pasquale initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Underweight rating and announces Price Target of $65.